WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H341099
CAS#: 13027-33-3
Description: Yakkasterone is a major metabolite of cholesterol formed during exposure of lung epithelial cells to ozone.
Hodoodo Cat#: H341099
Name: Yakkasterone
CAS#: 13027-33-3
Chemical Formula: C27H46O3
Exact Mass: 418.34
Molecular Weight: 418.662
Elemental Analysis: C, 77.46; H, 11.08; O, 11.46
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: Yakkasterone; YS 64.
IUPAC/Chemical Name: Cholestan-6-one, 3,5-dihydroxy-, (3beta,5alpha)-
InChi Key: SJZZRXMQSAXCFD-ZUDGWCDOSA-N
InChi Code: InChI=1S/C27H46O3/c1-17(2)7-6-8-18(3)21-9-10-22-20-15-24(29)27(30)16-19(28)11-14-26(27,5)23(20)12-13-25(21,22)4/h17-23,28,30H,6-16H2,1-5H3/t18-,19+,20+,21+,22+,23-,25-,26+,27+/m1/s1
SMILES Code: C1[C@@H](C[C@@]2(C(C[C@H]3[C@@H]4CC[C@@H]([C@@H](CCCC(C)C)C)[C@@]4(C)CC[C@H]3[C@@]2(C1)C)=O)O)O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 418.66 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Yamaguchi M, Endo Y, Shimizu M, Yamamoto K, Yamada S, Shudo K. 3 beta,5 alpha-Dihydroxycholestan-6-one exists in human blood. Biol Pharm Bull. 1997 Sep;20(9):1044-6. PubMed PMID: 9331996.
2: Matsushima Y, Fukasawa H, Endo Y, Hashimoto Y, Shudo K. Enhancement of human papillomavirus type 18 gene expression in HeLa cells by 12-O-tetradecanoylphorbol-13-acetate, 3 beta,5 alpha-dihydroxycholestan-6-one, and cholesterol. Biol Pharm Bull. 1994 Sep;17(9):1292-5. PubMed PMID: 7841956.
3: Endo Y, Hashimoto Y, Fukasawa H, Shudo K. Oxygenated cholesterols as ligands for cytosolic-nuclear tumor promoter binding protein: yakkasteroids. Biochem Biophys Res Commun. 1993 Aug 16;194(3):1529-35. PubMed PMID: 8352811.